EP3756767
MODULAR POINT-OF-CARE DEVICES AND USES THEREOF
Zusammenfassung
[0001] The present invention provides devices and systems for use at the point of care. The methods devices of the invention are directed toward automatic detection of analytes in a bodily fluid. The components of the device are modular to allow for flexibility and robustness of use with the disclosed methods for a variety of medical applications.
Anmelder
LABRADOR DIAGNOSTICS LLC [US]
Erfinder
BURD TAMMY [US]GIBBONS IAN [US]HOLMES ELIZABETH A [US]FRENZEL GARY [US]NUGENT ANTHONY JOSEPH [US]
Externe Quellen
Klassifikation
IPC-Klassen
B01J 19/00B01L 3/00B01L 3/02G01N 33/48G01N 33/53G01N 35/00G01N 35/02A61B 10/00A61B 10/02B01L 9/00G01N 33/543G16H 10/40
CPC-Klassen
A61B 5/15A61B 5/150755A61B 5/151B01J 19/0046B01L 3/0262B01L 3/5025B01L 3/527B01L 7/52B01L 9/543C12M 1/02C12M 1/266G01N 1/38G01N 33/48G01N 33/50G01N 33/5091G01N 33/53G01N 33/5302G01N 33/5304G01N 33/54326G01N 33/54366G01N 33/54386G01N 33/56966G01N 33/5758G01N 33/6803G01N 33/94G01N 35/00732G01N 35/00871G01N 35/02G01N 35/028G01N 35/08G01N 35/10G01N 35/1065G01N 35/1074G01N 37/00G16H 10/40
AI: Life SciencesManufacturing
warum
Labrador Diagnostics (Theranos successor) point-of-care — B01J + B01L + G01N + A61B10 + G16H. Life Science + Manufacturing. Rule agrees.